Abstract
A variant subline (B16-F10-B2) selected from the B16-F10 melanoma cell line, shows greater metastatic capacity and preferential growth in the brain after i.v. injection into C57BL/6 mice. Several biological properties of these two cell lines have been compared, in an effort to determine the mechanisms responsible for this non-random metastatic pattern. No differences in cell morphology, in vitro growth rates or exposed cell-surface proteins were detected. Quantitative analysis of tumour-cell arrest and distribution using 125IUdR-labelled cells indicated that, although initial arrest patterns of the cell lines were very similar, B16-F10-B2 cells survived in the lungs to a greater cell line had a higher mean number of chromosomes than the parent line, whereas the variance of chromosome distribution was less. We suggest that the selection of a brain-colonizing variant represents the emergence of a pre-existing subpopulation of cells, and provides a useful model for studying mechanisms of intracranial metastasis.
Full text
PDF










Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARONSON S. M., GARCIA J. H., ARONSON B. E. METASTATIC NEOPLASMS OF THE BRAIN: THEIR FREQUENCY IN RELATION TO AGE. Cancer. 1964 May;17:558–563. doi: 10.1002/1097-0142(196405)17:5<558::aid-cncr2820170503>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Ausman J. I., Shapiro W. R., Rall D. P. Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res. 1970 Sep;30(9):2394–2400. [PubMed] [Google Scholar]
- Brunson K. W., Beattie G., Nicolsin G. L. Selection and altered properties of brain-colonising metastatic melanoma. Nature. 1978 Apr 6;272(5653):543–545. doi: 10.1038/272543a0. [DOI] [PubMed] [Google Scholar]
- Brunson K. W., Nicolson G. L. Selection of malignant melanoma variant cell lines for ovary colonization. J Supramol Struct. 1979;11(4):517–528. doi: 10.1002/jss.400110410. [DOI] [PubMed] [Google Scholar]
- Conley F. K. Development of a metastatic brain tumor model in mice. Cancer Res. 1979 Mar;39(3):1001–1007. [PubMed] [Google Scholar]
- Conley F. K., Remington J. S. Nonspecific inhibition of tumor growth in the central nervous system: observations of intracerebral ependymoblastoma in mice with chronic Toxoplasma infection. J Natl Cancer Inst. 1977 Sep;59(3):963–973. doi: 10.1093/jnci/59.3.963. [DOI] [PubMed] [Google Scholar]
- Fidler I. J., Gersten D. M., Hart I. R. The biology of cancer invasion and metastasis. Adv Cancer Res. 1978;28:149–250. doi: 10.1016/s0065-230x(08)60648-x. [DOI] [PubMed] [Google Scholar]
- Fidler I. J. Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res. 1974 May;34(5):1074–1078. [PubMed] [Google Scholar]
- Fidler I. J., Kripke M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977 Aug 26;197(4306):893–895. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]
- Fidler I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst. 1970 Oct;45(4):773–782. [PubMed] [Google Scholar]
- Fidler I. J. Selection of successive tumour lines for metastasis. Nat New Biol. 1973 Apr 4;242(118):148–149. doi: 10.1038/newbio242148a0. [DOI] [PubMed] [Google Scholar]
- Fidler I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 1978 Sep;38(9):2651–2660. [PubMed] [Google Scholar]
- Gershbein L. L., Benuck I., Shurrager P. S. Brain changes and survival of animals with tumors implanted in the brain. Oncology. 1975;31(1):1–16. doi: 10.1159/000225000. [DOI] [PubMed] [Google Scholar]
- Hart I. R., Fidler I. J. Cancer invasion and metastasis. Q Rev Biol. 1980 Jun;55(2):121–142. doi: 10.1086/411730. [DOI] [PubMed] [Google Scholar]
- Hart I. R., Raz A., Fidler I. J. Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells. J Natl Cancer Inst. 1980 Apr;64(4):891–900. [PubMed] [Google Scholar]
- Marchalonis J. J., Cone R. E., Santer V. Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes. Biochem J. 1971 Oct;124(5):921–927. doi: 10.1042/bj1240921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel J. K., Didolkar M. S., Pickren J. W., Moore R. H. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg. 1978 Jun;135(6):807–810. doi: 10.1016/0002-9610(78)90171-x. [DOI] [PubMed] [Google Scholar]
- Posner J. B. Diagnosis and treatment of metastases to the brain. Clin Bull. 1974;4(2):47–57. [PubMed] [Google Scholar]
- Posner J. B., Shapiro W. R. Editorial: Brain tumor. Current status of treatment and its complications. Arch Neurol. 1975 Dec;32(12):781–784. doi: 10.1001/archneur.1975.00490540025002. [DOI] [PubMed] [Google Scholar]
- Poste G., Doll J., Hart I. R., Fidler I. J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 1980 May;40(5):1636–1644. [PubMed] [Google Scholar]
- RABSON A. S., KIRSCHSTEIN R. L., PAUL F. J. TUMORS PRODUCED BY ADENOVIRUS 12 IN MASTOMYS AND MICE. J Natl Cancer Inst. 1964 Jan;32:77–87. [PubMed] [Google Scholar]
- Strausbauch P., Sulica A., Givol D. General method for the detection of cells producing antibodies against haptens and proteins. Nature. 1970 Jul 4;227(5253):68–69. doi: 10.1038/227068a0. [DOI] [PubMed] [Google Scholar]
- Tao T., Matter A., Vogel K., Burger M. M. Liver-colonizing melanoma cells selected from B-16 melanoma. Int J Cancer. 1979 Jun 15;23(6):854–857. doi: 10.1002/ijc.2910230618. [DOI] [PubMed] [Google Scholar]
- Ushio Y., Chernik N. L., Shapiro W. R., Posner J. B. Metastic tumor of the brain: development of an experimental model. Ann Neurol. 1977 Jul;2(1):20–29. doi: 10.1002/ana.410020104. [DOI] [PubMed] [Google Scholar]




